MEDIPHASE

Serial Number 76149422
602

Registration Progress

Application Filed
Oct 17, 2000
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

MEDIPHASE

Basic Information

Serial Number
76149422
Filing Date
October 17, 2000
Abandonment Date
January 21, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 21, 2003
Classes
005

Rights Holder

PR Pharmaceuticals, Inc.

03
Address
1512 Webster Court
Fort Collins, CO 80524

Ownership History

PR Pharmaceuticals, Inc.

Original Applicant
03
Fort Collins, CO

Legal Representation

Attorney
Karen L Liepmann

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

6 events
Date Code Type Description Documents
Mar 21, 2003 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Oct 17, 2002 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 27, 2002 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 19, 2002 CNRT O NON-FINAL ACTION MAILED Loading...
Feb 27, 2001 CNSL F LETTER OF SUSPENSION MAILED Loading...
Feb 22, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the controlled delivery of, (i) hormone replacement and augmentation, and, (ii) medicines used in the treatment of cardiovascular disorders, anti-psychotic disorders, gastrointestinal disorders, metabolic disorders, microbial disorders, namely anti-viral, anti-bacterial, and anti-fungal preparations, and parasitic disorders, namely for treatment of endo and ecto parasites; and veterinary preparations for livestock, domestic pets, and companion animals for the controlled delivery of (i) hormone replacement and augmentation, and (ii) medicines used in the treatment of cardiovascular disorders, anti-psychotic disorders, gastrointestinal disorders, metabolic disorders, microbial disorders, namely anti-viral, anti-bacterial, and anti-fungal preparations, parasitic disorders, and anti-cancer treatments, namely for treatment of endo and ecto parasites,
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
MEDICAL PHASE

Classification

International Classes
005